ORLADEYO net revenue expected to be between $515-$535 million in 2025- -Total revenue (including RAPIVAB®) expected to be between $540-$560 million in 2025- -Company achieved operating profit in 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback